Elevated serum insulin-like growth factor 1 in recurrent aphthous stomatitis

Lorena Baccaglini, Jonathan J. Shuster, Douglas W. Theriaque, Zaeema Naveed

Research output: Contribution to journalArticle

Abstract

Over 100 million Americans experience recurrent aphthous stomatitis (RAS) at some point in life. To develop targeted drugs for RAS treatment, it is critical to identify its etiology. We determined if serum insulin-like growth factor 1 (IGF-1) and related factors are associated with RAS, because both RAS prevalence and IGF-1 are highest during puberty. We analyzed data from 1,480 Third National Health and Nutrition Examination Survey participants aged 20–40 years. Participants with a history of diabetes or lupus, cotinine levels 6 ng/ml or higher or glycemia 110 mg/dl or higher were excluded. We compared levels of IGF-1, IGFBP-3, leptin, and insulin in participants with a positive vs. negative RAS history in the prior 12 months. We used logistic regression in SAS/SUDAAN to account for the complex sampling design. The odds of a positive RAS history were 1.31 times higher for every 100 ng/ml increase in serum IGF-1. This association persisted after adjustment for age, race/ethnicity, medication intake, body mass index, insulin, leptin, glycemia, and income (adjusted OR = 1.30, 95% CI [1.06, 1.60]; p = 0.013). The odds of a positive RAS history were also higher among non-Hispanic white compared with non-Hispanic black participants (adjusted OR = 4.37, 95% CI [3.00, 6.38]). Leptin, IGFBP-3, and insulin levels did not differ by RAS status. The significantly higher IGF-1 levels in participants with a positive RAS history compared with controls suggest a possible role of the IGF-1 pathway in RAS etiology.

Original languageEnglish (US)
Pages (from-to)269-275
Number of pages7
JournalClinical and Experimental Dental Research
Volume5
Issue number3
DOIs
StatePublished - Jun 2019

Fingerprint

Somatomedins
Serum
Leptin
History
Insulin-Like Growth Factor Binding Protein 3
Insulin
Sutton disease 2
Cotinine
Nutrition Surveys
Puberty
Body Mass Index
Logistic Models

Keywords

  • IGF-1
  • aphthous stomatitis
  • growth factors
  • insulin
  • leptin

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Elevated serum insulin-like growth factor 1 in recurrent aphthous stomatitis. / Baccaglini, Lorena; Shuster, Jonathan J.; Theriaque, Douglas W.; Naveed, Zaeema.

In: Clinical and Experimental Dental Research, Vol. 5, No. 3, 06.2019, p. 269-275.

Research output: Contribution to journalArticle

Baccaglini, Lorena ; Shuster, Jonathan J. ; Theriaque, Douglas W. ; Naveed, Zaeema. / Elevated serum insulin-like growth factor 1 in recurrent aphthous stomatitis. In: Clinical and Experimental Dental Research. 2019 ; Vol. 5, No. 3. pp. 269-275.
@article{ef028adb23f24e52a9eab7d1df399266,
title = "Elevated serum insulin-like growth factor 1 in recurrent aphthous stomatitis",
abstract = "Over 100 million Americans experience recurrent aphthous stomatitis (RAS) at some point in life. To develop targeted drugs for RAS treatment, it is critical to identify its etiology. We determined if serum insulin-like growth factor 1 (IGF-1) and related factors are associated with RAS, because both RAS prevalence and IGF-1 are highest during puberty. We analyzed data from 1,480 Third National Health and Nutrition Examination Survey participants aged 20–40 years. Participants with a history of diabetes or lupus, cotinine levels 6 ng/ml or higher or glycemia 110 mg/dl or higher were excluded. We compared levels of IGF-1, IGFBP-3, leptin, and insulin in participants with a positive vs. negative RAS history in the prior 12 months. We used logistic regression in SAS/SUDAAN to account for the complex sampling design. The odds of a positive RAS history were 1.31 times higher for every 100 ng/ml increase in serum IGF-1. This association persisted after adjustment for age, race/ethnicity, medication intake, body mass index, insulin, leptin, glycemia, and income (adjusted OR = 1.30, 95{\%} CI [1.06, 1.60]; p = 0.013). The odds of a positive RAS history were also higher among non-Hispanic white compared with non-Hispanic black participants (adjusted OR = 4.37, 95{\%} CI [3.00, 6.38]). Leptin, IGFBP-3, and insulin levels did not differ by RAS status. The significantly higher IGF-1 levels in participants with a positive RAS history compared with controls suggest a possible role of the IGF-1 pathway in RAS etiology.",
keywords = "IGF-1, aphthous stomatitis, growth factors, insulin, leptin",
author = "Lorena Baccaglini and Shuster, {Jonathan J.} and Theriaque, {Douglas W.} and Zaeema Naveed",
year = "2019",
month = "6",
doi = "10.1002/cre2.181",
language = "English (US)",
volume = "5",
pages = "269--275",
journal = "Clinical and Experimental Dental Research",
issn = "2057-4347",
publisher = "John Wiley & Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Elevated serum insulin-like growth factor 1 in recurrent aphthous stomatitis

AU - Baccaglini, Lorena

AU - Shuster, Jonathan J.

AU - Theriaque, Douglas W.

AU - Naveed, Zaeema

PY - 2019/6

Y1 - 2019/6

N2 - Over 100 million Americans experience recurrent aphthous stomatitis (RAS) at some point in life. To develop targeted drugs for RAS treatment, it is critical to identify its etiology. We determined if serum insulin-like growth factor 1 (IGF-1) and related factors are associated with RAS, because both RAS prevalence and IGF-1 are highest during puberty. We analyzed data from 1,480 Third National Health and Nutrition Examination Survey participants aged 20–40 years. Participants with a history of diabetes or lupus, cotinine levels 6 ng/ml or higher or glycemia 110 mg/dl or higher were excluded. We compared levels of IGF-1, IGFBP-3, leptin, and insulin in participants with a positive vs. negative RAS history in the prior 12 months. We used logistic regression in SAS/SUDAAN to account for the complex sampling design. The odds of a positive RAS history were 1.31 times higher for every 100 ng/ml increase in serum IGF-1. This association persisted after adjustment for age, race/ethnicity, medication intake, body mass index, insulin, leptin, glycemia, and income (adjusted OR = 1.30, 95% CI [1.06, 1.60]; p = 0.013). The odds of a positive RAS history were also higher among non-Hispanic white compared with non-Hispanic black participants (adjusted OR = 4.37, 95% CI [3.00, 6.38]). Leptin, IGFBP-3, and insulin levels did not differ by RAS status. The significantly higher IGF-1 levels in participants with a positive RAS history compared with controls suggest a possible role of the IGF-1 pathway in RAS etiology.

AB - Over 100 million Americans experience recurrent aphthous stomatitis (RAS) at some point in life. To develop targeted drugs for RAS treatment, it is critical to identify its etiology. We determined if serum insulin-like growth factor 1 (IGF-1) and related factors are associated with RAS, because both RAS prevalence and IGF-1 are highest during puberty. We analyzed data from 1,480 Third National Health and Nutrition Examination Survey participants aged 20–40 years. Participants with a history of diabetes or lupus, cotinine levels 6 ng/ml or higher or glycemia 110 mg/dl or higher were excluded. We compared levels of IGF-1, IGFBP-3, leptin, and insulin in participants with a positive vs. negative RAS history in the prior 12 months. We used logistic regression in SAS/SUDAAN to account for the complex sampling design. The odds of a positive RAS history were 1.31 times higher for every 100 ng/ml increase in serum IGF-1. This association persisted after adjustment for age, race/ethnicity, medication intake, body mass index, insulin, leptin, glycemia, and income (adjusted OR = 1.30, 95% CI [1.06, 1.60]; p = 0.013). The odds of a positive RAS history were also higher among non-Hispanic white compared with non-Hispanic black participants (adjusted OR = 4.37, 95% CI [3.00, 6.38]). Leptin, IGFBP-3, and insulin levels did not differ by RAS status. The significantly higher IGF-1 levels in participants with a positive RAS history compared with controls suggest a possible role of the IGF-1 pathway in RAS etiology.

KW - IGF-1

KW - aphthous stomatitis

KW - growth factors

KW - insulin

KW - leptin

UR - http://www.scopus.com/inward/record.url?scp=85063511794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063511794&partnerID=8YFLogxK

U2 - 10.1002/cre2.181

DO - 10.1002/cre2.181

M3 - Article

C2 - 31249708

AN - SCOPUS:85063511794

VL - 5

SP - 269

EP - 275

JO - Clinical and Experimental Dental Research

JF - Clinical and Experimental Dental Research

SN - 2057-4347

IS - 3

ER -